Artificial Intelligence in Genomics Market Size & Growth Forecast 2027–2036, By Segments (Technology, Component, Functionality, Application, End-user), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Artificial Intelligence in Genomics Market size was valued at USD 1.53 Billion in 2026 and is projected to grow at 39.98% CAGR from 2027 to 2036, reaching USD 44.19 Billion by 2036. The industry revenue for 2027 is estimated at USD 2.07 Billion.
Get more details on this report
Request Free Sample ReportArtificial Intelligence in Genomics Market Intelligence Snapshot
Regional Market Dynamics
- North America held 53.46% in 2026, supported by advanced genomics research, AI adoption across life sciences, sequencing infrastructure, and precision medicine investment.
- Asia Pacific is expected to grow fastest as genomic medicine, sequencing capabilities, digital health infrastructure, and AI-enabled precision diagnostics expand.
Segment Momentum
- Machine learning accounted for 62.21% of the market in 2026 by enabling efficient analysis of complex genomic datasets, improving disease prediction, genetic variant interpretation, and AI-driven research workflows.
- Services are the fastest-growing component segment as organizations increasingly require AI implementation, system integration, data interpretation, and specialized support to manage complex genomic data effectively.
Market Expansion Drivers
- Rapid adoption of AI in precision medicine accelerating genomic data interpretation
- Rising genomics research investment improving drug discovery and biomarker identification
- AI-driven reduction in drug discovery turnaround time boosting R&D productivity
Leading Market Participants
- Leading players in the artificial intelligence in genomics market include Illumina, Inc. (United States), NVIDIA Corporation (United States), Microsoft Corporation (United States), IBM Corporation (United States), SOPHiA GENETICS SA (Switzerland), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (United States), Freenome Holdings, Inc. (United States), BenevolentAI plc (United Kingdom), Data4Cure, Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.53 Billion
- 2027 Estimated Market Size: USD 2.07 Billion
- Projected Market Size: USD 44.19 Billion by 2036
- Growth Forecast: 39.98% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Machine Learning (Technology) | Software (Component) | Genome Sequencing (Functionality) | Drug Discovery & Development (Application) | Pharmaceutical and Biotech Companies (End-user)
- Emerging Opportunity Segment: Machine Learning (Technology) | Service (Component) | Genome Sequencing (Functionality) | Precision Medicine (Application) | Healthcare Providers (End-user)
Market Growth Drivers and Industry Trends
Rapid adoption of AI in precision medicine accelerating genomic data interpretation
The increasing use of personalized healthcare approaches is creating demand for technologies that can analyze complex genomic information more efficiently. The artificial intelligence in genomics market growth is driven by AI adoption in precision medicine, where advanced algorithms help researchers and clinicians interpret large-scale genomic datasets and identify clinically relevant patterns. These capabilities are supporting more targeted treatment strategies and improving understanding of genetic factors associated with diseases.
Rising genomics research investment improving drug discovery and biomarker identification
Growing investments in genomic studies are expanding the need for computational tools that can process and analyze extensive biological datasets. The artificial intelligence in genomics market is benefiting from increased research activity focused on discovering new therapeutic targets, validating biomarkers, and improving disease characterization. AI-powered platforms enable researchers to identify relationships within genomic information that may support more efficient development of innovative medicines.
AI-driven reduction in drug discovery turnaround time boosting R&D productivity
Pharmaceutical and biotechnology organizations are increasingly adopting AI technologies to streamline research processes and accelerate complex discovery workflows. The artificial intelligence in genomics market growth is supported by AI-driven solutions that improve data analysis speed, automate pattern recognition, and enhance decision-making during drug development. By reducing manual analysis requirements and enabling faster evaluation of genomic insights, these technologies are improving overall R&D efficiency.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rapid adoption of AI in precision medicine accelerating genomic data interpretation | 2.4% | High | North America, Europe | High | Near Term |
| Rising genomics research investment improving drug discovery and biomarker identification | 2.2% | High | North America, Asia Pacific | High | Near Term |
| AI-driven reduction in drug discovery turnaround time boosting R&D productivity | 2.1% | High | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for 53.46% of the artificial intelligence in genomics market in 2026, supported by advanced genomics research capabilities, strong adoption of artificial intelligence across life sciences, and substantial investment in precision medicine. The region benefits from sophisticated sequencing infrastructure and a mature ecosystem for genomic data analysis, enabling AI technologies to assist with variant interpretation, biomarker discovery, disease risk assessment, and drug development. Increasing integration of computational tools into clinical and research workflows is further strengthening regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to witness the fastest growth as healthcare systems and research institutions increasingly invest in genomic medicine, biotechnology, and data-driven healthcare technologies. Expanding sequencing capabilities and growing interest in precision diagnostics are creating a broader need for AI-enabled analysis of complex genomic datasets. Government-supported research initiatives, improving digital health infrastructure, and increasing efforts to develop domestic capabilities in genomics and artificial intelligence are expected to accelerate regional adoption.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Scalable Genomic AnalyticsThe U.S. artificial intelligence in genomics market is driven by expanding genomic datasets and increasing integration of AI into precision medicine research. Organizations across the U.S. prioritize platforms that accelerate variant interpretation, biomarker discovery, and clinical decision support.
Germany 🇩🇪
Clinical Data IntegrationGermany is advancing artificial intelligence in genomics through secure integration of genomic data with clinical research and healthcare systems. Institutions in Germany emphasize interoperable AI solutions that support accurate diagnostics and regulatory-compliant data management.
Japan 🇯🇵
Precision Diagnostics SupportJapan leverages artificial intelligence in genomics to strengthen precision diagnostics and personalized treatment development. Research organizations and healthcare providers in Japan increasingly adopt AI tools that improve genomic interpretation while supporting translational medicine initiatives.
South Korea 🇰🇷
Bioinformatics AccelerationSouth Korea continues investing in artificial intelligence in genomics to strengthen bioinformatics capabilities and precision healthcare programs. Companies and research institutions in South Korea focus on AI platforms that streamline genomic analysis and improve research productivity.
France 🇫🇷
Translational Research EnablementFrance applies artificial intelligence in genomics to enhance collaboration between clinical research and healthcare institutions. Organizations in France prioritize AI-driven genomic interpretation that supports disease research, personalized therapies, and evidence-based clinical applications.
Italy 🇮🇹
Research Collaboration NetworksItaly is expanding artificial intelligence in genomics through collaborations among research centers, universities, and healthcare providers. Institutions in Italy increasingly adopt AI-enabled genomic analysis to improve research efficiency and strengthen precision medicine capabilities.
Segment Leadership and Growth Trends
Artificial Intelligence in Genomics Market Share (%), by Technology, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTechnology Segment Analysis: Machine Learning (Largest & Fastest-Growing Segment)
Holding the largest share of the artificial intelligence in genomics market, the machine learning segment accounted for 62.21% in 2026 while also emerging as the fastest-growing technology segment. Machine learning plays a central role in processing complex genomic datasets, identifying meaningful biological patterns, and improving the accuracy of disease prediction and genetic variant interpretation. Increasing integration of AI-driven analytics into genomic research, precision medicine, and drug discovery is strengthening adoption, while continuous advancements in computational models and expanding genomic databases are further reinforcing the segment’s leadership.
Component Segment Analysis: Software (Largest Segment) vs Service (Fastest-Growing Segment)
The software segment held the largest share of 56.6% in 2026. Software platforms form the foundation of AI-enabled genomics by supporting data integration, sequence analysis, predictive modeling, and visualization of complex genomic information. Growing demand for scalable bioinformatics solutions, cloud-based analytical platforms, and automated workflows is encouraging widespread software adoption across research institutions, healthcare organizations, and biotechnology companies.
The service segment is anticipated to register the fastest growth during the forecast period. As genomic datasets become increasingly complex, organizations are seeking specialized services for AI implementation, system integration, data interpretation, and ongoing technical support. The growing need for customized analytical solutions, regulatory compliance assistance, and expert consulting is expected to drive rising demand for professional and managed services within the market.
Functionality Segment Analysis: Genome Sequencing (Largest & Fastest-Growing Segment)
The genome sequencing segment dominated the artificial intelligence in genomics market with a 47.49% share in 2026 and is also expected to remain the fastest-growing functionality segment. AI-powered genome sequencing enables faster processing of extensive genetic data while improving the identification of disease-associated variants and supporting personalized treatment strategies. Expanding clinical adoption of genomic testing, increasing research focused on complex diseases, and continuous improvements in sequencing technologies are driving sustained demand for AI-enhanced genome sequencing solutions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Technology | Machine Learning, Computer Vision | Machine Learning | Machine Learning |
| Component | Software, Hardware, Service | Software | Service |
| Functionality | Genome Sequencing, Gene Editing, Others | Genome Sequencing | Genome Sequencing |
| Application | Drug Discovery & Development, Precision Medicine, Diagnostics, Others | Drug Discovery & Development | Precision Medicine |
| End-user | Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others | Pharmaceutical and Biotech Companies | Healthcare Providers |
Competitive Landscape and Market Positioning
Top players in the artificial intelligence in genomics market:
- Illumina, Inc. (United States)
- NVIDIA Corporation (United States)
- Microsoft Corporation (United States)
- IBM Corporation (United States)
- SOPHiA GENETICS SA (Switzerland)
- Deep Genomics Incorporated (Canada)
- Fabric Genomics, Inc. (United States)
- Freenome Holdings, Inc. (United States)
- BenevolentAI plc (United Kingdom)
- Data4Cure, Inc. (United States)
Artificial intelligence in genomics is becoming a technology-driven competitive arena where advantage is shifting toward organizations capable of combining advanced computational models with genomic expertise and scalable data capabilities. Market participants are differentiating through improvements in interpretation accuracy, automation of complex analysis workflows, and the ability to translate large biological datasets into actionable insights. Competition is expanding beyond algorithm development as successful players focus on building robust platforms that support research acceleration, clinical applications, and seamless integration into existing genomic workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Illumina Inc. (United States) | |||||||
| NVIDIA Corporation (United States) | |||||||
| Microsoft Corporation (United States) | |||||||
| IBM Corporation (United States) | |||||||
| SOPHiA GENETICS SA (Switzerland) | |||||||
| Deep Genomics Incorporated (Canada) | |||||||
| Fabric Genomics Inc. (United States) | |||||||
| Freenome Holdings Inc. (United States) | |||||||
| BenevolentAI plc (United Kingdom) | |||||||
| Data4Cure Inc. (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sidra Medicine | Dec-25 | Sidra Medicine joined the Hi-Fi Solves Alliance and secured PacBio-certified status to expand its AI-powered genomics capabilities via its Innovation Lab. The expansion accelerates precision medicine deployment and clinical genomic diagnostics through advanced computational infrastructure and global research collaborations. |
| Ultima Genomics, Inc. | Jun-22 | Ultima Genomics, Inc. integrated NVIDIA graphics processing units to accelerate deep learning algorithms for photometry and base calling applications. The technical collaboration enhances genome sequencing throughput, scaling operational efficiency and analytical accuracy across competitive AI-driven genomic platforms. |
| IBM | Mar-22 | IBM partnered with Genomics England to integrate advanced cloud services and AI capabilities into large-scale genomic datasets. The partnership optimizes computing infrastructure for global scientific researchers, accelerating discoveries in genomic data processing and expanding cloud-based market infrastructure. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Artificial Intelligence in Genomics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Genomic Data Type | DNA Sequence Data, RNA & Transcriptomic Data, Epigenomic Data, Multi-Omics Data |
| Deployment Model | Cloud-Based, On-Premises, Hybrid |
| Business Model | Subscription-Based, Usage-Based, Perpetual Licensing, Services-Based |
Artificial Intelligence in Genomics Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Genomic AI Commercialization Roadmap |
|
| Clinical Genomics AI Adoption Pathways |
|
| AI-Driven Drug Discovery Opportunities |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the artificial intelligence in genomics market?
What is the projected value of the artificial intelligence in genomics industry by 2036?
How is AI adoption in precision medicine reshaping demand in the artificial intelligence in genomics market?
Why are AI-powered platforms becoming a strategic investment for genomics research and drug discovery?
Why is machine learning the leading technology in the artificial intelligence in genomics market?
Which component segment is growing the fastest in the artificial intelligence in genomics market?
Why does North America lead the artificial intelligence in genomics market?
How is Asia Pacific driving future market growth?
Which companies are driving growth in the artificial intelligence in genomics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization